Fergal Delaney
About Fergal Delaney
Fergal Delaney is a Licensing Manager at Aspect Biosystems in Vancouver, Canada, with a background in business development and licensing in the biotechnology sector. He holds an MSc in Biotechnology and Business from UCD Michael Smurfit Graduate Business School and has worked with various organizations in Ireland and Canada.
Current Role at Aspect Biosystems
Fergal Delaney serves as the Licensing Manager at Aspect Biosystems, a position he has held since 2020. In this role, he is responsible for managing the company's patent portfolio, which plays a crucial part in supporting the organization's growth and success. His expertise in licensing and business development contributes to the strategic direction of the company.
Previous Experience at ERS Genomics
Prior to joining Aspect Biosystems, Fergal Delaney worked at ERS Genomics as the Business Development & Licensing Manager for Europe from 2018 to 2020. His role involved overseeing licensing agreements and business development initiatives, which helped to expand the company's reach in the European market.
Experience at Kinesis Health Technologies
Fergal Delaney's career includes a position as a Business Development Executive at Kinesis Health Technologies in 2018, where he worked for five months. He also served as a Business Development Intern at the same company from 2017 to 2018 for six months. His experiences at Kinesis provided him with foundational skills in business development within the health technology sector.
Educational Background
Fergal Delaney holds a Master of Science in Biotechnology and Business from UCD Michael Smurfit Graduate Business School, where he achieved Upper Second Class Honours with a GPA of 3.64. He completed this degree from 2016 to 2017. Additionally, he earned a Bachelor of Science in Genetics from University College Cork, where he studied various scientific disciplines including biochemistry and microbiology from 2012 to 2016.
Leadership and Projects During Studies
During his academic career, Fergal Delaney held leadership roles such as Membership Development Officer and Chairperson of the Genetics Society at University College Cork. He also developed a four-year feasibility and business plan for Phision Therapeutics, which included a pitch presentation for seed funding to a panel of experienced entrepreneurs and scientists.